Oestrogens are known to drive tumour growth in breast cancer cells that carry its receptors, but a new study by Duke Cancer Institute researchers unexpectedly finds...
Scientists have pinpointed thousands of genetic changes in a gene that may increase a person’s risk of developing breast and ovarian cancer, paving the way for...
The newer, 3D form of breast screening, known as digital breast tomosynthesis (DBT), is more effective at detecting breast cancer than traditional 2D digital mammography (DM). That’s...
The medtech start-up Cairn Surgical has secured US$4.5m in funding to improve breast cancer surgery. The round, led by Morningside Ventures, is hoped to help the...
A researcher from the University of Oxford has received new funding to study the role of neutrophils in ovarian cancer. Neutrophils are important cells in the...
The US cancer diagnostics start-up PreciseDx has secured US$20.7m in series B funding to “advance” AI-based cancer risk assessments. The round, which brings the company’s total...
Women’s cancer innovations will take centre stage at the second edition of the Femtech World Awards. The second annual Femtech World Awards aim to shine a...
Treatment with the iron-binding drug deferiprone elicits a natural killer cell response in a preclinical model of ovarian cancer
The US Food and Drug Administration (FDA) has approved Shorla Oncology’s new drug application for TEPYLUTE, a new formulation to treat breast and ovarian cancer. The...
Women in England are invited for screening by the NHS every three to five years depending on their age
